Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis
Cancer Epidemiology Biomarkers & Prevention2010Vol. 19(6), pp. 1409–1422
Citations Over TimeTop 10% of 2010 papers
Peddagangannagari Sreekanthreddy, Harish Srinivasan, Durairaj Mohan Kumar, Mamatha Bangalore Nijaguna, Sambandam Sridevi, Marigowda Vrinda, Arimappamagan Arivazhagan, Anandh Balasubramaniam, Alangar S. Hegde, Bangalore A. Chandramouli, Vani Santosh, Manchanahalli R.S. Rao, Paturu Kondaiah, Kumaravel Somasundaram
Abstract
Identified serum biomarkers may have potential utility in astrocytoma classification and GBM prognosis.
Related Papers
- → OLFML2A Downregulation Inhibits Glioma Proliferation Through Suppression of Wnt/β-Catenin Signaling(2021)12 cited
- → Aberrant Expression of N-Methylpurine-DNA Glycosylase Influences Patient Survival in Malignant Gliomas(2012)21 cited
- → The LncRNA RP11-279C4.1 Enhances the Malignant Behaviour of Glioma Cells and Glioma Stem-Like Cells by Regulating the miR-1273g-3p/CBX3 Axis(2021)12 cited
- → Microdensitometry of osteopontin as an immunohistochemical prognostic biomarker in colorectal carcinoma tissue microarrays: potential and limitations of the method in ‘biomarker pathology’(2012)3 cited
- → Correlation between CD133 and osteopontin expression and biological behariors of human brain glioma(2014)